PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

NCT06133517 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Bladder Carcinoma

Interventions

DRUG: Sacituzumab govitecan
DRUG: Zimberelimab
DRUG: Domvanalimab

Sponsor

Fundación para el Progreso de la Oncología en Cantabria

Collaborators

[object Object]